Guangdong Yuewei Edible Fungi Technology Co., Ltd., founded in 1998, is a technology company under the Guangdong Institute of Microbiology, specializing in the research and development of edible/medicinal mushroom efficacy, active ingredient extraction, new product development and other technical applications

Founded in 1998 and controlled by the Guangdong Institute of Microbiology and the core scientific research team, Guangdong Yuewei Edible Fungi Technology Co., Ltd. is a national high-tech enterprise integrating R&D, production, sales and OEM. The company specializes in the research and development of edible (medicinal) fungus efficacy, active ingredient extraction, new product development and other technical applications.

Yuewei has a standardized GMP factory of nearly 10,000 square meters, and has the leading international production lines such as Ganoderma lucidum spore enzymatic wall breaking, supercritical carbon dioxide extraction and edible fungus nutritional food. Through the combination of modern technology and traditional Chinese medicine concept, combined with the GMP management system, we condense high-quality Ganoderma lucidum products and achieve the confidence of customers.

Yuewei has an international vision, continues to cooperate with Canada and other developed countries in scientific research, and has established a global scientific research institute, undertaken more than 40 projects such as the national 12th Five-Year Plan science and technology support project and the national agricultural achievement transformation project, and applied for more than 60 domestic and foreign patents, among which the patent evaluation value of "Ganoderma lucidum spore endogenous enzyme wall breaking" technology is as high as 4.5 million.

At the same time, Ganoderma lucidum products are exported to developed countries and regions such as Europe and the United States all year round, and are welcomed and loved by people in the United States, Canada, the United Kingdom, Singapore, Hong Kong, Macao and Taiwan, and attract international counterparts including the United States to visit and study.

The company adheres to the health mission of "specializing in the research of 100 bacteria and Zhirun sentient beings", and strives for the common innovation and development of technology, quality and service.